Valeant Higher on Paulson Stake Increase; ImmunoGen Pops; Seattle Genetics Perplexes: Biotech Movers – TheStreet.com


TheStreet.com
Valeant Higher on Paulson Stake Increase; ImmunoGen Pops; Seattle Genetics Perplexes: Biotech Movers
TheStreet.com
Shares of Seattle Genetics Inc. (SGEN) fell 8.4% to $56.55 on Monday, June 26, as the company revealed Phase 3 study data for its Hodgkin lymphoma treatment. Though the data was positive and some on Wall Street expect the drug, adcetris, to be a $1.5 ...
Biotech Rally Stumbles As These Small Caps Pull BackInvestor's Business Daily
Bay State Biotech Report: Seattle Genetics and AlnylamBloomberg

all 46 news articles »

Read More

Biotech Rally Gets Second Wind As This Small Cap Nears Breaks Out – Investor’s Business Daily


Investor's Business Daily
Biotech Rally Gets Second Wind As This Small Cap Nears Breaks Out
Investor's Business Daily
Exelixis (EXEL) stock flirted with a breakout Monday, helping the biotech sector regain its speed on a seven-day running spree as worries that President Donald Trump's administration could handcuff drug prices continued to subside. In afternoon trading ...

and more »

Read More

Biotech Boom!: Overview And Company-By-Company Review … – Seeking Alpha


Investopedia
Biotech Boom!: Overview And Company-By-Company Review ...
Seeking Alpha
The biotech sector has been roaring back the past several weeks. Much of the reason relates to lessened anxiety over upcoming policies out of Washington, ...
The Reason for the Big Rise in Biotech Stocks | InvestopediaInvestopedia
iShares NASDAQ Biotechnology Index (ETF)(NASDAQ:IBB): Big ...ETF Daily News (blog)
Source reports record flows into biotech ETF | ETF StrategyETF Strategy

all 10 news articles »

Read More